News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
169 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21243)
Month
January (3049)
February (3199)
March (3214)
April (3461)
May (3810)
June (3552)
July (3330)
August (2848)
September (3192)
October (3888)
November (3400)
December (2467)
Day
3 (174)
4 (196)
5 (152)
6 (138)
7 (132)
10 (173)
11 (190)
12 (195)
13 (179)
14 (120)
17 (191)
18 (169)
19 (124)
20 (132)
21 (92)
24 (114)
25 (141)
26 (131)
27 (156)
28 (104)
31 (211)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
3
4
5
6
7
10
11
12
13
14
17
18
19
20
21
24
25
26
27
28
31
Business
Columbia Laboratories, Inc. to Restate Earnings Due to Adjustments for Interest Expense
March 18, 2008
·
1 min read
Drug Development
Immunomedics, Inc.'s Milatuzumab Receives FDA Orphan Drug Designation for Therapy of Multiple Myeloma
March 18, 2008
·
5 min read
Drug Development
Ardea Biosciences, Inc. Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
March 18, 2008
·
5 min read
Deals
QLT Inc. to Divest Acne Treatment Following FDA Ruling
March 18, 2008
·
1 min read
Drug Development
Cytopia Limited Nominates JAK2 Clinical Candidate for Myeloproliferative Disorders Clinical Study
March 18, 2008
·
3 min read
Business
NeoGenomics, Inc. Announces Results for the Fourth Quarter and Full Year FY 2007
March 18, 2008
·
8 min read
Business
Corgenix Medical Corporation Signs Technology Licensing Agreement With Japanese Government
March 18, 2008
·
3 min read
Biotech Bay
Ingenuity Systems Extends Enterprise-Level Software Agreement With GlaxoSmithKline
March 18, 2008
·
2 min read
Drug Development
Aegera Therapeutics Initiates Phase 1 Clinical Trial of AEG33773
March 18, 2008
·
1 min read
Pharm Country
Aceto Corporation To Present At Sidoti & Company’s Twelfth Annual New York Emerging Growth Institutional Investor Forumac
March 18, 2008
·
1 min read
Previous
4 of 17
Next